ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
117.143 IP-LS
Project title
Baxiva - Glycoconjugate VLP vaccines

Texts for this project
 GermanFrenchItalianEnglish
Key words
-
-
-
Anzeigen
Abstract
-
-
-
Anzeigen

Inserted texts


CategoryText
Key words
(English)
Life sciences, Pharmaceuticals
Abstract
(English)
Extraintestinal pathogenic E. coli (ExPEC) are the leading global cause of deaths from antibiotic resistant infections. This project focuses on development of prototypes and evaluation of feasibility of a multivalent glycoconjugate virus-like particle vaccine for the prevention of ExPEC infections.